Staar Surgical Target Price

Where could STAA trade next? Consensus target price: $30.

Get informed when a big investor buys or sells

+ Follow

Share Price

$22.66

Average Target Price

$30.11

32.9% upside

9 analysts in the last 4 months

High: $40 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-17	UBS	$28	23.6% upside
2026-08-13	JefferiesYoung Li	$28	23.6% upside
2026-08-13	William Blair	$33	45.6% upside
2026-08-13	UBS	$19	16.2% downside
2026-05-14	Mizuho SecuritiesAnthony Petrone	$27	19.2% upside
2026-05-14	Canaccord Genuity	$32	41.2% upside
2026-05-14	Wedbush	$40	76.5% upside
2026-05-14	Piper SandlerAdam Maeder	$33	45.6% upside
2026-05-14	Stifel NicolausThomas Stephan	$31	36.8% upside
2026-04-09	Canaccord Genuity	$27	19.2% upside
2026-03-04	Stifel Nicolaus	$18	20.6% downside
2026-02-09	Stifel Nicolaus	$19	16.2% downside
2026-02-03	Wedbush	$26	14.7% upside
2026-01-16	Morgan Stanley	$13	42.6% downside
2026-01-15	Canaccord GenuityJohn Young	$22	2.9% downside
2025-12-10	Wells FargoSimran Kaur	$30.75	35.7% upside
2025-12-09	Canaccord GenuityJohn Young	$30.75	35.7% upside
2025-10-21	Canaccord GenuityJohn Young	$28	23.6% upside
2025-08-07	Stifel NicolausThomas Stephan	$28	23.6% upside
2024-06-11	BTIGRyan Zimmerman	$46	103% upside
2024-04-09	JefferiesRaj Denhoy	$60	164.8% upside
2024-04-08	Canaccord GenuityJohn Young	$46	103% upside
2024-04-04	William BlairMargaret Kaczor	$45.03	98.7% upside
2023-01-11	StephensStephens Stephens	$85	275.1% upside
2022-09-23	Truist Financial	$48	111.8% upside
2022-09-23	RBC Capital	$52	129.5% upside
2022-07-19	Truist Financial	$54	138.3% upside
2022-04-26	Canaccord Genuity	$89	292.8% upside
2022-03-23	Truist FinancialMichael Ciarmoli	$58	156% upside

Staar Surgical (STAA) FAQ

As of the most recent data, STAA shows a target price of $30. Scroll down for historical charts and peer comparison views.

If Staar Surgical moved to the average analyst target of $30, shares would be roughly 32.9% higher than $22.66. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Staar Surgical's earnings trajectory.

Besides this target price page, Stockcircle has Staar Surgical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $30) with ownership activity and broader fundamentals.

Staar Surgical's target price is $30; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.